Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
Draft as of 2018-07-02 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="valueset-cyclosporine-exclude"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1093178</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]</td></tr><tr><td>402092</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]</td></tr><tr><td>1093177</td><td>Cyclosporine Ophthalmic Ointment [Optimmune]</td></tr><tr><td>402330</td><td>Cyclosporine Ophthalmic Suspension [Restasis]</td></tr><tr><td>1093174</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment</td></tr><tr><td>351291</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension</td></tr><tr><td>1093173</td><td>Cyclosporine Ophthalmic Ointment</td></tr><tr><td>378766</td><td>Cyclosporine Ophthalmic Suspension</td></tr><tr><td>1156187</td><td>Cyclosporine Ophthalmic Product</td></tr><tr><td>1182342</td><td>Optimmune Ophthalmic Product</td></tr><tr><td>1182527</td><td>Restasis Ophthalmic Product</td></tr></table></li></ul></div>
</text>
<url
value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude"/>
<version value="1.0.0-ballot"/>
<name value="Valueset_cyclosporine_exclude"/>
<title value="Exclude cyclosporine Medications Value Set"/>
<status value="draft"/>
<experimental value="true"/>
<date value="2018-07-02"/>
<publisher value="HL7 Clinical Decision Support Workgroup"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
</coding>
</jurisdiction>
<purpose value="To refine valueset for Digoxin + Cyclosporine PDDI-CDS"/>
<copyright value="(copyright expectations unknown)"/>
<compose>
<include>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<concept>
<code value="1093178"/>
<display
value="Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]"/>
</concept>
<concept>
<code value="402092"/>
<display
value="Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]"/>
</concept>
<concept>
<code value="1093177"/>
<display value="Cyclosporine Ophthalmic Ointment [Optimmune]"/>
</concept>
<concept>
<code value="402330"/>
<display value="Cyclosporine Ophthalmic Suspension [Restasis]"/>
</concept>
<concept>
<code value="1093174"/>
<display value="Cyclosporine 0.002 MG/MG Ophthalmic Ointment"/>
</concept>
<concept>
<code value="351291"/>
<display value="Cyclosporine 0.5 MG/ML Ophthalmic Suspension"/>
</concept>
<concept>
<code value="1093173"/>
<display value="Cyclosporine Ophthalmic Ointment"/>
</concept>
<concept>
<code value="378766"/>
<display value="Cyclosporine Ophthalmic Suspension"/>
</concept>
<concept>
<code value="1156187"/>
<display value="Cyclosporine Ophthalmic Product"/>
</concept>
<concept>
<code value="1182342"/>
<display value="Optimmune Ophthalmic Product"/>
</concept>
<concept>
<code value="1182527"/>
<display value="Restasis Ophthalmic Product"/>
</concept>
</include>
</compose>
</ValueSet>